EQS-News: aap Implantate AG: Appointment of new board members and change of CEO at aap Implantate AG

aap Implantate AG announced leadership changes as part of a succession plan. CEO Rubino Di Girolamo will leave the Management Board early and step down at the end of the year, waiving the remaining term of his contract, with effect from December 31, 2026. The Supervisory Board appointed Cornelius Fink to the Management Board as COO (and responsible for trauma) effective August 19, 2026, noting he has worked at the company in managerial operational roles and already taken on additional responsibilities. It also appointed Nicole Kassel as CFO effective August 19, 2026, citing that she has led the finance department for almost a year. The company said it is reorganizing management to support its next growth phase, after achieving full MDR certification and advancing its LOQTEQ® technology.